HCM
Price:
$10.28
Market Cap:
$1.80B
HUTCHMED (China) Limited is a biopharmaceutical firm dedicated to the discovery, advancement, and marketing of innovative targeted and immune-based treatments for various cancers and immune-related disorders. Its operations are divided into two main areas: Oncology/Immunology and a segment encompassing Other Ventures. The company's reach extends from Hong Kong globally. Among its pipeline, HUTCHMED is developing Savolitinib, an inhibitor targeting non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC). Another key therapeutic, Fruquintinib, is an inhibitor being investigated for its efficacy in CRC, breast cancer, GC, endometr...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-03-16
Stock Exchange
NASDAQ
Ticker
HCM
According to HUTCHMED (China) Limited’s latest financial reports and current stock price. The company's current PE Ratio is 3.88. This represents a change of -98.84% compared to the average of 335.24 of the last 4 quarters.
The mean historical PE Ratio of HUTCHMED (China) Limited over the last ten years is 12.71. The current 3.88 PE Ratio has changed 2.95% with respect to the historical average. Over the past ten years (40 quarters), HCM's PE Ratio was at its highest in in the March 2016 quarter at 3.89K. The PE Ratio was at its lowest in in the March 2018 quarter at -108.48.
Average
12.71
Median
-18.05
Minimum
-178.18
Maximum
388.66
Discovering the peaks and valleys of HUTCHMED (China) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.92%
Maximum Annual PE Ratio = 388.66
Minimum Annual Increase = -518.77%
Minimum Annual PE Ratio = -178.18
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 5.00 | -92.44% |
| 2024 | 66.10 | 120.92% |
| 2023 | 29.92 | -518.77% |
| 2022 | -7.14 | -75.32% |
| 2021 | -28.95 | -32.97% |
| 2020 | -43.20 | 22.82% |
| 2019 | -35.17 | -49.74% |
| 2018 | -69.98 | -60.73% |
| 2017 | -178.18 | -145.85% |
| 2016 | 388.66 | -419.85% |
The current PE Ratio of HUTCHMED (China) Limited (HCM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
33.67
5-year avg
12.98
10-year avg
12.71
HUTCHMED (China) Limited’s PE Ratio is greater than Bausch Health Companies Inc. (-1.49), greater than Perrigo Company plc (-0.78), greater than IDEAYA Biosciences, Inc. (-19.77), greater than Supernus Pharmaceuticals, Inc. (-86.78), less than Catalyst Pharmaceuticals, Inc. (17.43), greater than Scholar Rock Holding Corporation (-13.72), greater than Adaptive Biotechnologies Corporation (-53.54), greater than Mineralys Therapeutics, Inc. (-12.01), greater than Cidara Therapeutics, Inc. (-18.63), less than Kiniksa Pharmaceuticals, Ltd. (56.23),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.49 | $1.78B | |
| -0.78 | $1.42B | |
| -19.77 | $2.95B | |
| -86.78 | $2.58B | |
| 17.43 | $3.84B | |
| -13.72 | $5.67B | |
| -53.54 | $2.81B | |
| -12.01 | $1.63B | |
| -18.63 | $5.61B | |
| 56.23 | $4.14B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HUTCHMED (China) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HUTCHMED (China) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HUTCHMED (China) Limited's PE Ratio?
How is the PE Ratio calculated for HUTCHMED (China) Limited (HCM)?
What is the highest PE Ratio for HUTCHMED (China) Limited (HCM)?
What is the 3-year average PE Ratio for HUTCHMED (China) Limited (HCM)?
What is the 5-year average PE Ratio for HUTCHMED (China) Limited (HCM)?
How does the current PE Ratio for HUTCHMED (China) Limited (HCM) compare to its historical average?